Citadel Advisors
FBIO icon

Citadel Advisors’s Fortress Biotech FBIO Stock Holding History

Citadel Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-53,100
Closed -$194K – 13322
2025
Q4 		$194K Sell
53,100
-112,400
-68% -$320K ﹤0.01% 11070
2025
Q3 		$612K Buy
+165,500
New +$418K ﹤0.01% 8636
2025
Q1 		– Sell
-29,700
Closed -$60.1K – 14782
2024
Q4 		$60.1K Buy
29,700
+26,000
+703% +$47.1K ﹤0.01% 12176
2024
Q3 		$5.35K Sell
3,700
-2,700
-42% -$5.14K ﹤0.01% 13504
2024
Q2 		$10.9K Buy
6,400
+5,900
+1,180% +$10.7K ﹤0.01% 13061
2024
Q1 		$1K Sell
500
-1,200
-71% -$2.39K ﹤0.01% 14207
2023
Q4 		$5.12K Sell
1,700
-687
-29% -$1.82K ﹤0.01% 13453
2023
Q3 		$10.4K Buy
2,387
+2,007
+528% +$13.8K ﹤0.01% 13066
2023
Q2 		$3.13K Sell
380
-687
-64% -$6.79K ﹤0.01% 13716
2023
Q1 		$13.1K Buy
+1,067
New +$12.7K ﹤0.01% 13374
2021
Q4 		– Sell
-3,040
Closed -$147K – 14055
2021
Q3 		$147K Sell
3,040
-3,673
-55% -$179K ﹤0.01% 12402
2021
Q2 		$360K Buy
+6,713
New +$405K ﹤0.01% 10824
2015
Q3 		– Sell
-593
Closed -$30K – 8970
2015
Q2 		$30K Sell
593
-174
-23% -$8.93K ﹤0.01% 7960
2015
Q1 		$44K Buy
+767
New +$32K ﹤0.01% 7457
2014
Q3 		– Sell
-320
Closed -$8K – 8191
2014
Q2 		$8K Sell
320
-153
-32% -$4.03K ﹤0.01% 7627
2014
Q1 		$14K Sell
473
-267
-36% -$10.4K ﹤0.01% 7406
2013
Q4 		$29K Buy
+740
New +$28.6K ﹤0.01% 6286

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors's FBIO Position: Q1 2026 in Review

Citadel Advisors opened a new position in Fortress Biotech (FBIO) in Q1 2026: 180,289 shares worth $503K. The stake represents ﹤0.01% of the portfolio and ranks #9293 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in FBIO as recently as Q2 2025.

Citadel Advisors first reported a position in FBIO in Q3 2013 and has held it in 25 quarters since. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Citadel Advisors held 180,289 shares of Fortress Biotech worth $503K as of Q1 2026.
  • Fortress Biotech was a new Citadel Advisors position in Q1 2026.
  • Fortress Biotech made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9293 holding.
  • Citadel Advisors first reported a position in Fortress Biotech in Q3 2013 and has held it in 25 quarters since.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.